Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Sprint’s CEO says deals like Verizon’s Yahoo purchase never work out

Marcelo Claure says his video strategy is smarter: Offering unlimited data, not buying content.

Sprint CEO Marcelo Claure, speaking at the 2015 Code Conference.
Sprint CEO Marcelo Claure, speaking at the 2015 Code Conference.
Sprint CEO Marcelo Claure
| Asa Mathat

Sprint CEO Marcelo Claure said Monday that Verizon’s purchase of Yahoo is just the latest in a long history of deals by telecom firms trying to get into the content business, none of which have panned out.

“History has proven that every single one of them has failed,” Claure said on a conference call with reporters following the company’s quarterly earnings report.

AT&T has gobbled up DirecTV while Verizon has been buying up internet giants AOL and now Yahoo and trying to prop up its Go90 video service.

“We like when we see our [competitors] take their eye off their core business,” Claure said. He took a shot at Go90, saying it has set some sort of record for least amount of return for the amount of money Verizon has spent.

As for Sprint’s video strategy, Claure said his focus is on giving customers unlimited data and letting them choose what video content they want to watch. However, Sprint has been raising the price of such plans, which once were offered for as little as $50 per month but now cost $75 monthly for new customers.

T-Mobile, meanwhile, has its Binge On program, which offers customers the ability to view video from Netflix, Hulu and a host of other video services at reduced quality without using any data from their monthly allotment.

One concern for Sprint has been that parent company SoftBank’s $32 billion deal to acquire chipmaker ARM will leave little capital to invest further in Sprint or to fund a potential deal to acquire T-Mobile.

Claure put a positive spin on the deal, noting that SoftBank chief Masayoshi Son wouldn’t have bought ARM unless he was convinced Sprint was on solid footing.

“We are really not even thinking about T-Mobile,” Claure said.

Sprint’s quarterly earnings and revenue were generally in line with what analysts were expecting as the company added 377,000 customers, including 173,000 of the most lucrative type — those of the non-prepaid variety.

Shares of Sprint were trading Monday at $5.49, up 87 cents or 18 percent.

This article originally appeared on Recode.net.

See More:

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh